MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-14-2023
Biocept Long Term Debt Current 2011-2026 | BIOC
Annual Long Term Debt Current Biocept
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 518 K | 426 K | - | 842 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 842 K | 426 K | 595 K |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
662 K | $ 1.29 | -20.86 % | $ 1.72 M |  USA |
 |
Castle Biosciences
CSTL
|
1.32 M | $ 19.22 | 1.8 % | $ 557 M | USA |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 15.84 | -2.16 % | $ 479 M | USA |
 |
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
79 M | $ 141.26 | -1.38 % | $ 22.5 B | USA |
 |
Interpace Biosciences
IDXG
|
431 K | $ 1.8 | - | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
6.52 M | $ 19.81 | -3.34 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
3.8 M | $ 93.52 | -3.26 % | $ 6.31 B | USA |
 |
Medpace Holdings
MEDP
|
23.2 M | $ 417.74 | -0.34 % | $ 12.1 B | USA |
 |
Mettler-Toledo International
MTD
|
35.1 M | $ 1 039.9 | -0.19 % | $ 21.4 B |  Schweiz |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Myriad Genetics
MYGN
|
6.9 M | $ 3.61 | -0.41 % | $ 334 M | USA |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
4.78 M | $ 8.28 | -0.96 % | $ 1.06 B | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
451 K | $ 18.7 | -1.22 % | $ 419 M | USA |
 |
Natera
NTRA
|
7.64 M | $ 188.14 | -4.45 % | $ 18.5 B | USA |
 |
Charles River Laboratories International
CRL
|
57.7 M | $ 154.29 | -3.04 % | $ 7.65 B | USA |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
241 M | $ 25.27 | -0.9 % | $ 24 B |  Niderland |
 |
Guardant Health
GH
|
27.7 M | $ 94.56 | -4.16 % | $ 11.9 B | USA |
 |
Personalis
PSNL
|
6.89 M | $ 6.45 | -3.95 % | $ 576 M | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 117.67 | 0.5 % | $ 9.71 B |  Irlanda |
 |
Senseonics Holdings
SENS
|
496 K | $ 5.7 | -2.06 % | $ 238 M | USA |
 |
Soleno Therapeutics
SLNO
|
726 K | $ 52.99 | - | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
358 K | $ 2.36 | -2.07 % | $ 5.42 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
191 M | $ 251.95 | -0.81 % | $ 21 B | USA |
 |
Thermo Fisher Scientific
TMO
|
275 M | $ 439.75 | -1.87 % | $ 166 B | USA |
 |
Celcuity
CELC
|
54 K | $ 134.2 | -0.39 % | $ 6.27 B | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
13.8 M | $ 48.67 | -8.08 % | $ 2.91 B | USA |
 |
Neogen Corporation
NEOG
|
5.64 M | $ 8.22 | -2.49 % | $ 1.78 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
174 M | $ 187.17 | -0.41 % | $ 20.8 B | USA |
 |
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | USA |